Sector revisions GlaxoSmithKline Pharmaceuticals Limited

Stocks

Market Closed - Bombay S.E. Other stock markets 06:00:48 2026-06-16 EDT			5-day change	1st Jan Change
2,201.15 ^INR	+3.60%		+0.81%	-10.92%

05-29	GlaxoSmithKline Pharmaceuticals Limited Announces Resignation of Dr. Simrat Sohal from Compliance Officer and Ceases to Be the Senior Management Personnel, Effective August 5, 2026	CI
05-13	GlaxoSmithKline Pharmaceuticals Clocks Higher Fiscal Q4 Consolidated Net Profit	MT

Sector:

Location:

X axis:

Main competitors

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	1m. Revenue rev.	4m. EPS revision	4m. Revenue rev.	1y. EPS revision	1y. Revenue rev.	Visibility	Nbr of analysts
	GLAXOSMITHKLINE PHARMACEUTICALS LIMITED							4
	ELI LILLY AND COMPANY							29
	JOHNSON & JOHNSON							23
	ABBVIE INC.							29
	ROCHE HOLDING AG							17
	NOVARTIS AG							21
	ASTRAZENECA PLC							21
	NOVO NORDISK A/S							23
	AMGEN INC.							30
	GILEAD SCIENCES, INC.							28
	PFIZER INC.							27
	BRISTOL-MYERS SQUIBB COMPANY							25
	VERTEX PHARMACEUTICALS INCORPORATED							29
	SANOFI							23
	GSK PLC							19
	CHUGAI PHARMACEUTICAL CO., LTD.							15
	TAKEDA PHARMACEUTICAL COMPANY LIMITED							15
	JIANGSU HENGRUI PHARMACEUTICALS CO.,LTD							16
	BAYER AG							19
	TEVA PHARMACEUTICAL INDUSTRIES LIMITED							10
	Average							21
	Weighted average by Cap.							25